Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-09 5:00 pm Sale |
2023-08-09 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 0 0.000% |
-7,877,862 (Position Closed) |
Filing History |
| 2023-07-10 10:20 am Sale |
2023-07-07 | 13G | DICE Therapeutics, Inc. DICE |
FMR CORP | 2,239,223 4.688% |
-2,958,134 (-56.92%) |
Filing History |
| 2023-06-23 5:10 pm Sale |
2023-06-22 | 13D | DICE Therapeutics, Inc. DICE |
Northpond Ventures, LP | 800,000 1.700% |
-2,492,871 (-75.71%) |
Filing History |
| 2023-06-22 4:32 pm Sale |
2023-06-20 | 13D | DICE Therapeutics, Inc. DICE |
Sands Capital Life Sciences Pulse Fund II. L.P. | 1,886,470 4.000% |
-1,262,500 (-40.09%) |
Filing History |
| 2023-06-21 5:00 pm Purchase |
2023-06-18 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 7,877,862 16.500% |
217,247 (+2.84%) |
Filing History |
| 2023-03-29 5:14 pm Purchase |
2023-03-27 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 7,660,615 16.100% |
811,704 (+11.85%) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | DICE Therapeutics, Inc. DICE |
PRICE T ROWE ASSOCIATES INC | 3,219,960 6.800% |
3,219,960 (New Position) |
Filing History |
| 2023-02-14 09:32 am Purchase |
2022-12-31 | 13G | DICE Therapeutics, Inc. DICE |
AVORO CAPITAL ADVISORS LLC | 2,525,555 5.300% |
2,525,555 (New Position) |
Filing History |
| 2023-02-13 2:27 pm Purchase |
2022-12-31 | 13G | DICE Therapeutics, Inc. DICE |
BLACKROCK INC BLK |
3,052,102 6.400% |
3,052,102 (New Position) |
Filing History |
| 2023-02-09 09:59 am Sale |
2023-02-09 | 13G | DICE Therapeutics, Inc. DICE |
FMR CORP | 5,197,357 10.902% |
-96,658 (-1.83%) |
Filing History |
| 2022-11-10 4:15 pm Unchanged |
2022-11-09 | 13D | DICE Therapeutics, Inc. DICE |
Northpond Ventures, LP | 3,292,871 6.900% |
0 (Unchanged) |
Filing History |
| 2022-11-10 11:55 am Purchase |
2022-11-09 | 13G | DICE Therapeutics, Inc. DICE |
FMR CORP | 5,294,015 11.107% |
5,294,015 (New Position) |
Filing History |
| 2022-11-10 09:23 am Sale |
2022-10-31 | 13G | DICE Therapeutics, Inc. DICE |
DRIEHAUS CAPITAL MANAGEMENT INC | 1,915,496 4.020% |
-231,146 (-10.77%) |
Filing History |
| 2022-10-19 4:37 pm Purchase |
2022-10-17 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 6,848,911 14.400% |
1,640,000 (+31.48%) |
Filing History |
| 2022-02-14 09:24 am Purchase |
2021-12-31 | 13G | DICE Therapeutics, Inc. DICE |
DRIEHAUS CAPITAL MANAGEMENT INC | 2,146,642 5.610% |
2,146,642 (New Position) |
Filing History |
| 2021-09-28 06:04 am Purchase |
2021-09-17 | 13D | DICE Therapeutics, Inc. DICE |
Northpond Ventures, LP | 3,292,871 9.100% |
3,292,871 (New Position) |
Filing History |
| 2021-09-27 4:32 pm Purchase |
2021-09-17 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 5,208,911 14.300% |
5,208,911 (New Position) |
Filing History |
| 2021-09-24 6:12 pm Purchase |
2021-09-17 | 13D | DICE Therapeutics, Inc. DICE |
Sands Capital Life Sciences Pulse Fund II. L.P. | 3,148,970 8.700% |
3,148,970 (New Position) |
Filing History |